Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.
The results were less favorable than expected, but experts -- and women who participated in the trial -- would like to see this prevention tool approved for use.
The ECHO trial faces backlash and criticism.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
Could home-based self-swabs and mobile technology be helpful tools in the future of HIV prevention?
No meaningful difference was found in either injectable or implant birth control when compared to an IUD.
Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.
"We don't need to spend another $140 million to find out how to retain people in care," activist David Barr writes. "We need to invest in the kinds of services people need so that they can use treatment easily and effectively."
Viral load cut-off as defined by WHO guidelines fails to identify a significant number of HIV positive people at risk for virological failure, according to findings from South Africa presented at the 11th INTEREST workshop.
The prevalence of transmitted drug resistance is above the WHO threshold of 5% in this study conducted in rural South Africa.